NUTEX Investments has been growing earnings at an average annual rate of 52.4%, while the Pharmaceuticals industry saw earnings growing at 8.8% annually. Revenues have been growing at an average rate of 0% per year. NUTEX Investments's return on equity is 9%, and it has net margins of 109815.8%.
How NUTEX Investments makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
BUSE:NUTEX Revenue, expenses and earnings (HUF Millions)
Date
Revenue
Earnings
G+A Expenses
R&D Expenses
31 Dec 25
0
494
109
0
30 Sep 25
0
383
162
0
30 Jun 25
0
271
216
0
31 Mar 25
0
347
156
0
31 Dec 24
0
423
97
0
30 Sep 24
0
444
58
0
30 Jun 24
0
464
19
0
31 Mar 24
0
317
20
0
31 Dec 23
0
171
21
0
30 Sep 23
0
121
21
0
30 Jun 23
0
71
21
0
31 Mar 23
0
101
19
0
31 Dec 22
0
131
16
0
30 Sep 22
0
115
15
0
30 Jun 22
0
99
14
0
31 Mar 22
0
56
14
0
31 Dec 21
0
13
13
0
30 Sep 21
0
-10
14
0
30 Jun 21
0
-32
14
0
31 Mar 21
0
-3
16
0
31 Dec 20
0
26
19
0
30 Sep 20
0
15
18
0
30 Jun 20
0
4
18
0
31 Mar 20
0
-2
14
0
31 Dec 19
1
-8
10
0
Quality Earnings: NUTEX has a high level of non-cash earnings.
Growing Profit Margin: NUTEX's current net profit margins are higher than last year .
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: NUTEX's earnings have grown significantly by 52.4% per year over the past 5 years.
Accelerating Growth: NUTEX's earnings growth over the past year (16.7%) is below its 5-year average (52.4% per year).
Earnings vs Industry: NUTEX earnings growth over the past year (16.7%) exceeded the Pharmaceuticals industry 15.3%.
Return on Equity
High ROE: NUTEX's Return on Equity (9%) is considered low.
Return on Assets
Return on Capital Employed
Discover strong past performing companies
7D
1Y
7D
1Y
7D
1Y
Company Analysis and Financial Data Status
Data
Last Updated (UTC time)
Company Analysis
2026/06/05 18:55
End of Day Share Price
2026/06/05 00:00
Earnings
2025/12/31
Annual Earnings
2025/12/31
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
NUTEX Investments Public Limited Company is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.